Raybow PharmaScience attending Chemoutsourcing in Parsippany, New Jersey

Raybow PharmaScience attending Chemoutsourcing in Parsippany, New Jersey Image

Brevard, NC - August 29, 2022

Raybow PharmaScience is attending this three day trade show and conference which gets underway September 7th, 2022. The event was on hiatus due to Covid. The 2022 edition of the show is sold out

Raybow attended the last edition of the show in 2019. Key executives attending the event include Peter Halkjaer-Knudsen, Executive Vice President, Gerard Scarlator, Head of Business Development - West and Fazal Chaudhry, Director of Business Development - East.

"This has always been a great show for us" said Halkjaer-Knudsen. "It is always nice when we get to meet our clients and suppliers face-to-face."

Peter has been invited to speak on three panel discussions at the event including;

  • Wednesday 4:00PM - "Keynote 2022: CMC, API & Global Supply Chain Security in the Post-Pandemic World"
  • Thursday 9:00AM - "Small Molecule API Supply Chain Post-Pandemic: Price Inflation, CDMO Capacity Constraints, Raw Materials, Logistical Challenges"
  • Thursday 1:30PM - "What's Going On In China? Risk Mitigation, Lockdowns, Ports, Shipping, Reshoring, Chinese Manufacturing Expansion in USA & Europe"

The in-person event runs for 3 days, ending on the 8th. Raybow will round out the year attending Bio Europe October 24th to 26th and CPhI Worldwide in Frankfurt, Germany November 1st through the 3rd.

Raybow PharmaScience is a global Contract Drug and Manufacturing Organization (CDMO) with operations in China, Europe and the U.S. Raybow is focused on providing world class research and development capabilities in the pharmaceutical manufacturing space. Raybow has shown its commitment to the R&D side of the business launching two 10,000 square meter R&D centers in the past 3 years alone and hiring more than 600 new chemists in that same time frame.

Other Raybow News & Papers

Privileged Chiral Spiro Ligands and Applications to Commercially Marketed APIs

Privileged Chiral Spiro Ligands and Applications to Commercially Marketed APIs

Raybow PharmaScience attending Chemoutsourcing in Parsippany, New Jersey

Raybow is attending Chemoutsourcing in Parsippany, New Jersey September 7th-9th.

Raybow PharmaScience Attends CPhI Worldwide in Fiera Milano, Milan, Italy

Raybow is attending CPhI Worldwide in Milan, Italy.

Raybow Pharmaceutical Announces Rebranding, Changes Name to Raybow PharmaScience

Raybow has unveiled changes to its’ name, with modifications to the iconic Rainbow Logo as part of a rebranding initiative designed to better reflect the company’s commitment to science.

Raybow PharmaScience announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow PharmaScience announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce